Biotechnological potential of mushrooms: Drugs and dye production

International Journal of Medicinal Mushrooms

Volumn 8, Issue 4, 2006, Pages 351-360

  Tidke, Girish ^a   Rai, Mahendra ^a  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Antibiotics; Antitumor; Biotechnological potential; Cardiovascular; Dye; Immunomodulatory; Medicinal mushrooms

Indexed keywords

GLUCAN; HERBACEOUS AGENT; LENTINAN; LENTINUS EDODES MYCELIUM EXTRACT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGARICUS BISPORUS; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; AURICULARIA AURICULA; BIOTECHNOLOGY; CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG SCREENING; FLAMMULINA VELUTIPES; GANODERMA LUCIDUM; GRIFOLA; HUMAN; HYPERCHOLESTEROLEMIA; LENTINUS EDODES; MUSHROOM; NONHUMAN; OPPORTUNISTIC INFECTION; PLEUROTUS; PLEUROTUS OSTREATUS; PROTOZOAL INFECTION; REVIEW; SCHIZOPHYLLUM COMMUNE; TRAMETES VERSICOLOR; TRICHOLOMA MATSUTAKE;

AGARICUS; AGARICUS BISPORUS; AGARICUS BRASILIENSIS; AURICULARIA AURICULA-JUDAE; BASIDIOMYCOTA; CORIOLOPSIS; DAEDALEA; FLAMMULINA VELUTIPES; GANODERMA APPLANATUM; GANODERMA LUCIDUM; GRIFOLA FRONDOSA; HEXAGONIA (FUNGUS); HYPHODONTIA; LAETIPORUS SULPHUREUS; LENTINULA EDODES; LENZITES BETULINA; LYCOPERDON; PHAEOLUS; PHOLIOTA NAMEKO; PLEUROTUS OSTREATUS; POLYPORUS; POLYPORUS BRUMALIS; SCHIZOPHYLLUM COMMUNE; TRAMETES VERSICOLOR; TRICHOLOMA MATSUTAKE;

EID: 33846668281     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v8.i4.60     Document Type: Review

References (58)

1. Alberts A. W., MacDonald J. S., Till A. E., and Tobert J. A. 1989. Lovastatin. Cardiovascular Drug Rev, 7, 89-109.
2. Anke T. 1989. Basidiomycetes: a source of new bioactive secondary metabolites. Progr Industr Microbiol, 27, 51-66.
3. Aroche R. M., Aguilar O., Bonavides J., Valenzuela R., Linares V., and Miranda M. A. 1988. Laetiporus sulphureus: una especie con potential cosmetible, Medicinally tintoreo. Resumenes. III Congreso Nacionale de Micologia, Cd. Victoria, Tams, Mexico.
4. Atri N. S. and Saini S. S. 2000. Collection and study of Agarics -An Introduction. Indian J Mushr, 18, 1-5.
5. Bhide V. P., Pande A., Sathe A. V., Rao V. G., and Patwardhan P. G. 1987. Fungi of Maharashtra (Supp.1) M.A.C.S. Pub., Pune, India, 146 pp.
6. Bobek P., Ginter E., Jurcovicova M., Ozdin L., and Mekinova D. 1991. Cholesterol lowering effect of the mushroom Pleurotus ostreatus in hereditary hypercholesterolemic rats. Ann Nutr Metabol, 5, 191-195.
7. Butler E. J. and Bisby G. R. 1931. The Fungi of India. Imp. Coun. of Agric. Res. Sci. Mono. Calcutta, 1, XVIII, 237 pp.
8. Cedano M., Villasenor L., and Guzman Davalos L. 2000. Some Aphyllophorales tested for organic dyes. Mycologist, 15(2), 81-85.
9. Chambers W. 1990. Arctic Lichen dyes. In Dyes form Nature, Plants & Gardens, Brooklyn Botanic Garden Record, 46(2), 46-48.
10. Chihara G., Maeda Y. Y., Hamuro J., Sasaki T., and Fukuoka F. 1969. Inhibition of mouse Sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) Sing. Nature (London), 222, 687-688.
11. Chihara G., Hamuro J., Maeda Y. Y., Arai Y., and Fukuoka F. 1970a. Antitumor polysaccharides derived chemically from natural glucan (pachyman). Nature (London), 255, 943-944.
12. Chihara G., Hamuro J., Maeda Y. Y., Arai Y., and Fukuoka F. 1970b. Fractionation and purification of the polysaccharides with marked antitumor activity, especially Lentinan, from an edible mushroom Lentinus edodes (Berk.) Singer. Cancer Res, 30, 2776-2781.
13. Chihara G., Hamuro J., Maeda Y. Y., Shiio T., Suga T., Takasuka N., and Sasaki T. 1987. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview. Cancer Detect Prev, (Suppl.), 1, 423-443.
14. Gorin P. A. J. and Barreto-Berger E. 1983. The Chemistry of Polysaccharides of Fungi and Lichens. In: The Polysaccharides. Vol. 2, G. O. Aspinall, ed., Academic Press, New York, pp. 365-409.
15. Gunde-Cimmermann N. 1999. Medicinal value of the genus Pleurotus (Fr.) P. Krast. (Agaricales s. e., Basidiomycetes). Int JMed Mushr, 1, 69-80.
16. Guzmali G. 1997. Los Nombres De Los Hongos Y Lo Relacionado Con Ellos En America Latina. Instituto De Ecologia, Xalapa.
17. Hobbs Ch. 1995. Medicinal Mushrooms: An Exploration of Traditional, Healing and Culture. Botanica Press, Santa Cruz, CA, 251 pp.
18. Ikekawa T. 2001. Beneficial effects of edible and medicinal mushrooms on health care. Int J Med Mushr, 3, 291-298.
19. Khan Z. K. and Shukla P. K. 1992. Screening techniques for antimicrobial and antifungal activity. UNISCO-CDRI, Workshop on the Use of Pharmacological Techniques for the Study of Natural Products, March 30-April 14.
20. Kiho T., Morimoto H., Kobayashi T., Usiu S., Ukai S., Aizawa K, and Inakuma T. 2000. Effects of polysaccharide (TAP) from the fruiting bodies of Tremella aurantia on glucose metabolism in mouse liver. Biosci Biotechnol Biochem, 64, 417-149.
21. Kiho T., Nagai Y. S., Sakushima M., and Ukai S. 1992a. Polysaccharides in fungi. XXIX. Structural features of two antitumor polysaccharides from the fruiting bodies of Armillariella tabescens. Chem Pharm Bull (Tokyo), 40, 2212-2214.
22. Kiho T., Nagai K., and Ukai S. 1992b. Polysaccharides in fungi. XXX. Antitumor and immunomodulating activities of two polysaccharides from the fruiting of Armillariella tabescens. Chem Pharm Bull (Tokyo), 40, 2110-2214.
23. Lakhanpal T. N. 1995. Mushroom flora of North West Himalayas. In: Advances in Horticulture Vol.13. Mushrooms, K. L. Chandra and S. R. Sharma eds., MPH, New Delhi, pp. 351-373.
24. Lorenzen K. and Anke T. 1998. Basidiomycetes as a source for new bioactive natural product. Curr Org Chem, 2, 329-364.
25. Manjula B. 1983. A revised list of agrigicoid and boletoid basidiomycetes from India and Nepal. Proc Indian Acad Sci (Plant Sci), 92, 81-213.
26. Mizuno T. 1995a. Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. Food Rev Int, 11(1), 7-21.
27. Mizuno T. 1995b. Shiitake, Lentinus edodes: functional properties for medicinal and food purposes. Food Rev Int, 11(1), 111-128.
28. Mizuno T. 1996. A development of antitumor polysaccharides from mushroom fungi. Food Ingred J (Japan), 167, 69-85.
29. Mizuno T. 2000. Development of an antitumor biological response modifier from Phellinus linteus (Berk. et Curt.) Teng (Aphyllophoromycetedeae) Int J Med Mushr, 2, 21-33.
30. Mizuno T. 2002. Medicinal properties and clinical effects of Agaricus blazei Murrill (review). Int J Med Mushr, 4, 299-313.
31. Mizuno T., Sakai T., and Chihara G. 1995. Health foods and medicinal usages of mushrooms. Food Rev Int, 11(1), 69-82.
32. Natrajan K. and Raman N. 1983. South Indian Agaricales. Today and Tomorrow Printers and Publishers, New Delhi, 204 pp.
33. Ohno N., Adachi Y., Suzuki I., Sato K., Oikawa S., and Yadomae T. 1986. Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa. Chem Pharm Bull (Tokyo), 34, 1709-1715.
34. Ohno N., Iino K., Takeyama T., Suzuki I., Sato K., Oikawa S., Miyazaki T., and Yadomae T. 1985. Structural characterization and antitumor activity of the extracts from matted mycelium of cultured Grifola frondosa. Chem Pharm Bull (Tokyo), 33, 3395-3401.
35. Ooi V. E. C. 2000. Medicinally important fungi. In: Science and Cultivation of Edible Fungi. Van Griensven, ed., Balkema, Rotterdam, pp. 41-51.
36. Ooi V. E. C. and Liu F. 1999. A review of pharmacological activities of mushroom polysaccharides. Int J Med Mushr, 1, 195-206.
37. Purkayastha R. P. and Chandra A. 1985. Manual of Indian Edible Mushrooms. Jagmander Book Agency, New Delhi, 267 pp.
38. Rai M. K. 1997. Wild edible mushrooms of tribal areas of Seoni District, Madhya Pradesh. Mushr Res, 6(2), 107-108.
39. Rai M. K., Tidke, G., and Wasser S. P. 2005. Therapeutic potential of mushrooms, Natural Product Radiance, 4(4), 246-257.
40. Reshetnikov S. V., Wasser S. P., and Tan K. K. 2001. Higher Basidiomycota as a source of antitumor and immunomodulating polysaccharides (Review). Int J Med Mushr, 3, 361-394.
41. Rice M. and Beebee D. 1980. Mushrooms for Colour. Mad River Press, Eureka, CA, 153 pp.
42. Rosenfield L. 1989. Atherosclerosis and the cholesterol connection: revolution of clinical applications. Clin Chem, 35, 521-531.
43. Stamets P. 2000. Growing Gourmet and Medicinal Mushrooms. 3 ed. Ten Speed Press, Berkeley, CA, 573 pp.
44. Suay I., Arenal F., Asensio F. J., Basilio A., Cabello M A., Diez M. T., Garcia J. B., del Val A. G., Corrochategui J., Hernandez P., Pelaez F., and Vicente M. F. 2000. Screening of Basidiomycetes for antimicrobial activities. Antonie van Leeuwenhoek, 78, 129-139.
45. Uptom J. 1990. Blue dyes from Xanthoria lichens. In: Dyes from Nature, Plants & Gardens, Brooklyn Botanic Garden Record, 46(20), 49-50.
46. Verma R. N., Singh G. B., and Bilgramy K. S. 1987. Fleshy Fungal Flora of NEH India.-I. Manipur and Meghalaya. In: Indian Mushroom Science II, T. N. Kaul and B. M. Kapoor, eds., RRL CSIR Jammu Tawi, pp. 414-421.
47. Vrinda K. B., Pradeep C. K., Mathew S., and Abraham T. K. 1999. Agaricales from Western Ghats VII. Mushr Res, 8, 9-12.
48. Wasser S. P. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol, 60, 258-274.
49. Wasser S. P. 2005a. Reishi or Ling Zhl (Ganoderma lucidum). In: Encyclopedia of Dietary Supplements. P. M. Coates et al., eds. Marcel Dekker, New York, pp 603-620.
50. Wasser S. P. 2005b. Shitake (Lentinus edodes). In: Encyclopedia of Dietary Supplements. P. M. Coates et al., eds. Marcel Dekker, New York, pp. 653-664.
51. Wasser S. P. and Weis A. L. 1999a. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: Current perspectives (Review). Int J Med Mushrs, 1, 31-62.
52. Wasser S. P. and Weis A. L. 1999b. Therapeutic effects of substances occurring in higher Basidiomycete mushrooms: a modern perspective. Crit Rev Immunol, 19, 65-96.
53. Wasser S. P. and Didukh M. Ya. 2005. Culinary medicinal higher basidiomycete mushrooms as a prominent source of dietary supplements and drugs for the 21st century, In: Proceedings of 5th International Conferenceof Mushroom Biology and Mushroom products, Q. Tan, J. Zhang, M. Chen, H. Cao, and J. A. Buswell, ed., Sanghai, China, v. 12, pp. 20-34.
54. Wasson G. R. 1969. Soma-Divine Mushroom of Immortality. Harcourt, Brace and Jovanovich, New York, 318 pp.
55. Yuexin L., Zhuqiu Ye., Yana H., and Hauling X. 2002. Fractionation and characterization of water-soluble polysaccharides from culinary medicinal mushroom, Agaricus blazei Murrill (Agaricomycetideae) fruit body. Int J Med Mushr, 4, 131-121.
56. Zhang H. N. and Lin Z. B. 2004. Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol Sin, 25(2), 191-195.
57. Zhuang C., Mizuno T., Shimada A., Ito H., Suzuki C., Mayuzumi Y., Okamoto H., Ma Y., and Li J. 1993. Antitumor protein-containing polysaccharides from a Chinese mushroom Fengweigu or Houbitake, Pleurotus sajor-caju (Fr.) Sing. Biosci Biotechnol Biochem, 57, 901-906.
58. Zhuang C. and Wasser S. P. 2004. Medicinal value of culinary-medicinal maitake mushroom Grifola frondosa (Dicks.:Fr.) S.F.Gray (Aphyllophoromycetideae). Review. Int J Med Mushr, 6, 287-313.